Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04006626
What this trial is testing

18F-FES PET/CT's Additional Clinical Value in ER+ BC

Who this might be right for
Breast Cancer
Fudan University 19
Not applicableActive Not RecruitingNCT00935090
What this trial is testing

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Barbara Ann Karmanos Cancer Institute
Not applicableStudy completedNCT01879657
What this trial is testing

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

Who this might be right for
Neuroendocrine Carcinoma
Radio Isotope Therapy of America 169
Not applicableActive Not RecruitingNCT02293954
What this trial is testing

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Who this might be right for
Breast CancerColon CancerExtrahepatic Bile Duct Cancer+9 more
City of Hope Medical Center 20
Not applicableStudy completedNCT06809426
What this trial is testing

Evaluating the Safety and Efficacy of 177Lu-LNC1011 Injection in a Single-Center, Single-Arm, Open Study in Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Desmoplasia-Resistant Prostate Cancer

Who this might be right for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Affiliated Hospital of Jiangnan University 13
Very early researchLooking for participantsNCT06914999
What this trial is testing

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+13 more
Emory University
Not applicableEnded earlyNCT02700763
What this trial is testing

[18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis

Who this might be right for
Melanoma
University Medical Center Groningen 1
Post-approval studies (Phase 4)Study completedNCT02234492
What this trial is testing

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

Who this might be right for
Human Immunodeficiency Virus (HIV)Cardiovascular Disease (CVD)
Ottawa Heart Institute Research Corporation 35
Early research (Phase 1)Study completedNCT00756366
What this trial is testing

CPAP Therapy in Patients With Heart Failure and Obstructive Sleep Apnea.

Who this might be right for
Heart FailureObstructive Sleep Apnea
Ottawa Heart Institute Research Corporation 67
Testing effectiveness (Phase 2)Study completedNCT06695039
What this trial is testing

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer

Who this might be right for
Breast Cancer Invasive
Asan Medical Center 71
Not applicableUnknownNCT05914402
What this trial is testing

Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET

Who this might be right for
Breast Cancer
Fudan University 100
Not applicableUnknownNCT04971369
What this trial is testing

Safety Study of 89Zr-NY001 PET Imaging in Patients

Who this might be right for
Solid Tumor, Adult
Wuxi No. 4 People's Hospital 20
Not applicableEnded earlyNCT01571739
What this trial is testing

Determining Risk in Latent Tuberculosis

Who this might be right for
Latent Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Looking for participantsNCT07314073
What this trial is testing

[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer

Who this might be right for
Stage III Breast Cancer
Asan Medical Center 85
Large-scale testing (Phase 3)Looking for participantsNCT05749289
What this trial is testing

Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression

Who this might be right for
SSTR Positive Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 400
Early research (Phase 1)UnknownNCT02972697
What this trial is testing

Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB

Who this might be right for
Tuberculosis, Pulmonary
National University Hospital, Singapore 5
Not applicableUnknownNCT04693169
What this trial is testing

[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients

Who this might be right for
Prostate Cancer
Peking University Cancer Hospital & Institute 20
Not applicableLooking for participantsNCT06790264
What this trial is testing

Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer

Who this might be right for
Breast Cancer InvasiveNode Positive Breast Cancer
European Institute of Oncology 92
Not applicableEnded earlyNCT01712815
What this trial is testing

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerStage IA Breast Cancer+6 more
University of Southern California 12
Testing effectiveness (Phase 2)Ended earlyNCT02736448
What this trial is testing

177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors

Who this might be right for
Gastro-entero-pancreatic Neuroendocrine Tumors
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 35
Next Page
20